Showing results (1-10 of 132) with videos related to
Sort By:
Pageof 14
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Topical treatment for cutaneous leishmaniasisTracy Garnier, Simon L CroftThe Journal of Pharmacy and Pharmacology|July 29, 2006
In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasisTracy Garnier, Marc B Brown, M Jayne Lawrence, et al.The Journal of Pharmacy and Pharmacology|January 18, 2007
Topical buparvaquone formulations for the treatment of cutaneous leishmaniasisTracy Garnier, Antti Mäntylä, Tomi Järvinen, et al.Journal of Medicinal Chemistry|December 30, 2003
Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquoneAntti Mäntylä, Tracy Garnier, Jarkko Rautio, et al.Bioorganic & Medicinal Chemistry|June 10, 2004
Synthesis and antileishmanial activity of novel buparvaquone oxime derivativesAntti Mäntylä, Jarkko Rautio, Tapio Nevalainen, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|August 10, 2005
Public-private partnership: from there to hereSimon L CroftParasitology|October 7, 2017
Leishmania and other intracellular pathogens: selectivity, drug distribution and PK-PDSimon L CroftGenome Biology|March 16, 2016
Neglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administrationSimon L CroftCurrent Pharmaceutical Design|February 28, 2002
Chemotherapy of leishmaniasisSimon L Croft, Vanessa YardleyAntimicrobial Agents and Chemotherapy|December 27, 2005
In vitro and in vivo interactions between miltefosine and other antileishmanial drugsKarin Seifert, Simon L CroftPageof 14